ARCT - Arcturus Therapeutics Holdings Inc.
IEX Last Trade
16.88
0.060 0.355%
Share volume: 6,438
Last Updated: Thu 26 Dec 2024 08:30:15 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$16.82
0.06
0.36%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-09 | 2023-03-29 | 2023-05-09 | 2023-08-07 | 2023-11-14 | 2024-03-14 | 2024-05-08 | |
| Total revenue | 27.093 M | 13.369 M | 160.293 M | 80.285 M | 10.519 M | 45.140 M | 30.855 M | 38.012 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 27.093 M | 13.369 M | 160.293 M | 80.285 M | 10.519 M | 45.140 M | 30.855 M | 38.012 M | |
| -50.66% | 1,098.99% | -49.91% | -86.90% | 329.13% | -31.65% | 23.20% | |||
| Operating expenses | 49.182 M | 50.176 M | 38.841 M | 65.530 M | 65.893 M | 64.454 M | 49.127 M | 68.424 M | |
| Selling general and admin | 10.993 M | 12.488 M | 11.860 M | 13.762 M | 13.225 M | 13.377 M | 12.507 M | 14.851 M | |
| Research and development | 38.189 M | 37.688 M | 26.981 M | 51.768 M | 52.668 M | 51.077 M | 36.620 M | 53.573 M | |
| Total expenses | 49.313 M | 50.176 M | 38.841 M | 65.530 M | 65.893 M | 64.454 M | 49.127 M | 68.424 M | |
| 1.75% | -22.59% | 68.71% | 0.55% | -2.18% | -23.78% | 39.28% | |||
| Operating income | -22.220 M | -36.807 M | 121.452 M | 14.755 M | -55.374 M | -19.314 M | -18.272 M | -30.412 M | |
| Ebit | -22.220 M | -36.807 M | 121.452 M | 14.755 M | -55.374 M | -19.314 M | -18.272 M | -30.412 M | |
| Pretax income | -21.563 M | -35.266 M | 118.642 M | 50.857 M | -51.973 M | -15.329 M | -11.445 M | -26.449 M | |
| 63.55% | -436.42% | -57.13% | -202.19% | -70.51% | -25.34% | 131.10% | |||
| Income tax | 0.000 | 0.000 | 1.295 M | 103.000 K | 577.000 K | 893.000 K | 262.000 K | 368.000 K | |
| Net income basic | -21.563 M | -35.266 M | 117.347 M | 50.754 M | -52.550 M | -16.222 M | -11.707 M | -26.817 M | |
| -63.55% | 432.75% | -56.75% | -203.54% | 69.13% | 27.83% | -129.07% | |||
| Net income | -21.563 M | -35.266 M | 117.347 M | 50.754 M | -52.550 M | -16.222 M | -11.707 M | -26.817 M | |
| -63.55% | 432.75% | -56.75% | -203.54% | 69.13% | 27.83% | -129.07% |